BioGenes is a full-service provider of customized immunoassay and antibody development as well as a comprehensive range of analytical services with a strong commitment to quality and service.
Founded in 1992 and headquartered in Berlin, Germany, BioGenes is a recognized partner serving more than 600 customers in 40 countries. The company maintains long-term relationships with CMOs, pharma, biotech and diagnostic companies. BioGenes provides highly customized solutions for the manufacturing quality control of biological products, for drug discovery and drug development as well as for diagnostic purposes.
The company has a proven track record in the development, qualification, pre-validation and production of highly sensitive and robust ELISAs, e.g. for host cell protein (HCP) monitoring and pharmacokinetic and immunogenicity studies. Furthermore, BioGenes is specialized in sophisticated custom monoclonal, polyclonal and anti-idiotypic antibody development for several purposes.